Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.

Slides:



Advertisements
Similar presentations
Diabetes Prevention Program
Advertisements

99.98% of the time patients are on their own “The diabetes self-management regimen is one of the most challenging of any for chronic illness.” 0.02% of.
Main Trial Design and Trial Status
Power Point Presentation to Tribal Leaders To gain support, orientate, and as a method of Buy In of the tribal leaders a PowerPoint on the grant progress.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Texas Diabetes Education & Care Management Project Funded by Bristol-Myers Squibb Foundation Bureau of Primary Health, HRSA CDC Diabetes Prevention (in-kind.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,
Competitive Grant Program Core Elements Evaluation Overview Yvette Roubideaux, MD, MPH.
Competitive Grant Program: Year 2 Meeting 2. SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 2 HH Data Coordinator Training.
CVD Risk Reduction Group Recruitment Core Elements July 2005.
SDPI Healthy Heart Project SDPI Competitive Grant Program Technical Assistance Meeting October 23-24, 2006 Tucson, AZ Core Elements: Case Management and.
Community Based Activities Yvette Roubideaux MD MPH University of Arizona.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
Laying the Foundation for Success: SDPI Demonstration Projects Overview November19, 2010 SPECIAL DIABETES PROGRAM FOR INDIANS Healthy Heart Project Initiative:
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Competitive Grant Program: Year 2 Meeting 2. SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 2 SPECIAL DIABETES PROGRAM.
IHS Special Diabetes Program Competitive Grants Part 1: Introduction to Idea Mapping Cardiovascular Disease Prevention Planning Cynthia C. Phillips, Ph.D.
IHS Special Diabetes Program Competitive Grants Part 2: Refining Idea Maps Cardiovascular Disease Prevention Planning Cynthia C. Phillips, Ph.D. Lisa Wyatt.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
SDPI Competitive Grant Program Planning Meeting 1 IHS Diabetes Competitive Grant Program: Overview and Update Kelly Acton, MD, MPH, FACP Director, IHS.
Yvette Roubideaux MD MPH Zuckerman College of Public Health
IHS Special Diabetes Program Competitive Grants Part 2: Using Idea Maps to Plan for Evaluation CVD Risk Reduction Group Cynthia C. Phillips, Ph.D. Lisa.
Core Elements.  Recruitment Goals = 48 new participants each year  Recruitment for Intensive Activities 1. Recruitment Team 2. Team Meetings  Invitation.
Competitive Grant Program Data Coordinator Training Overview Yvette Roubideaux, MD, MPH.
New Dataset Overview July 28, 2009 SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects: Year 5 Meeting 1.
Core Elements: Case Management Recruitment Yvette Roubideaux, MD, MPH.
Core Elements: DPP Curriculum DP Recruitment Yvette Roubideaux, MD, MPH.
SDPI Healthy Heart Project SDPI Competitive Grant Program Technical Assistance Meeting October 23-24, 2006 Tucson, AZ Core Elements: Case Management –
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
CVD Risk Reduction Group Case Management Core Elements: Update July 2005.
CVD Risk Reduction Group Case Management Core Elements May 2005.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Northern England Strategic Clinical Network Conference Rahul Nayar SCN – Diabetes Lead 15 th May 2015.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
GPRA Government Performance and Results Act Mary Brickell, IT Specialist, GPRA Coordinator Portland Area Indian Health Service March 2012.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Cardiovascular Health and Risk Reduction in Children and Adolescents
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Joint Effects of Routine Blood Pressure Lowering and Intensive Glucose Control ADVANCE Adapted from EASD 2008.
IMPROVING DIABETES CARE FOR ADULTS: A Population-Based Approach Patrick J. O’Connor, MD, MPH Senior Clinical Investigator HealthPartners Research Foundation.
Using Healthy Heart Data by Rick Frey, PhD Toiyabe Indian Health Project, Inc. A collection of PowerPoint slides that have been used in grant applications,
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Healthy Heart Initiative and the Role of the Pharmacist Alexis Beyer, PharmD, NCPS Cherokee Indian Hospital Healthy Heart Pharmacist.
William C. Cushman, MD, FACP, FAHA Veterans Affairs Medical Center, Memphis, TN For The ACCORD Study Group.
NATIONAL D I ABET ES DEI TACUON PROGRA M Changing the way diabetes is treated.
HvC Comparative Effectiveness Project Groups 5 and 6
+ Effects of Quality Improvement Strategies on Diabetes Care Presented by: Cali Trepp, Caitlin Dowhie, and Rosa Sanchez.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
3 rd Annual Right Care Summit October 1 st, 2010 Stephen M. Shortell Ph.D., M.P.H. Dean, University of California, Berkeley, School of Public Health.
Polypill x Aspirin Project Groups 3 and 4
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.
ACCORD Eye Study Results
Blood Pressure and Lipid Trials: Rationale, Importance and Design
Redefining Quality Care in T2DM Patients with CV Disease
The SPRINT Research Group
Hypertension in the Post SPRINT era
Vanguard Phase Results for the Blood Pressure Component
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Diabetes Health Status Report
Systolic Blood Pressure Intervention Trial (SPRINT)
Select Topics in Cardiovascular Medicine
Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes.
Presentation transcript:

Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention

The CVD Risk Reduction Demonstration Project We know “what” but we don’t know “how”

The CVD Risk Reduction Demonstration Project  Core elements – “what”  Development of intensive intervention– “how”  Collaborative process  Standards of Care  Case Management

The CVD Risk Reduction Demonstration Project  8 Core elements - Intensive Intervention Identify eligible individuals with Diabetes Recruit individuals with diabetes to participate Initial physical exam and baseline measures Case Management approach to clinic visits

The CVD Risk Reduction Demonstration Project  8 Core elements – Intensive Intervention Treat CVD risk factors to recommended target levels Education on diabetes and CVD risk reduction – group or individual Gather data on required evaluation measures Target number of participants per year = 50

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics A1C, % Mean A1C, *p< comparing mean HbA1 levels in FY94 and Y03 year

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics A1C % Glycemic control, *p< comparing mean HbA1 levels in FY94 and Y03 year

Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics BP, mm Hg Mean Systolic & Diastolic BPs, year

IHS Diabetes Care & Outcomes Audit Source: IHS National Diabetes Program Statistics Mean Lipid Values mg/dl year

The CVD Risk Reduction Demonstration Project  Less intensive intervention Community activities for people at risk for diabetes and cardiovascular disease and their families Focus on diabetes and cardiovascular disease risk reduction Tailor to community needs Evaluate activities

The CVD Risk Reduction Demonstration Project  Collaborative process  New way of doing business  Work outside our comfort levels

The CVD Risk Reduction Demonstration Project  Homework: review IHS Standards of Care for Diabetes Your recent (3-5 year) audit results NHLBI Curriculum – “Honoring the Gift of Heart Health”